Cargando…
cMET inhibitor crizotinib impairs angiogenesis and reduces tumor burden in the C3(1)-Tag model of basal-like breast cancer
Epidemiologic studies have associated obesity with increased risk of the aggressive basal-like breast cancer (BBC) subtype. Hepatocyte growth factor (HGF) signaling through its receptor, cMET, is elevated in obesity and is a pro-tumorigenic pathway strongly associated with BBC. We previously reporte...
Autores principales: | Cozzo, Alyssa J., Sundaram, Sneha, Zattra, Ottavia, Qin, Yuanyuan, Freemerman, Alex J., Essaid, Luma, Darr, David B., Montgomery, Stephanie A., McNaughton, Kirk K., Ezzell, J. Ashley, Galanko, Joseph A., Troester, Melissa A., Makowski, Liza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799044/ https://www.ncbi.nlm.nih.gov/pubmed/27057482 http://dx.doi.org/10.1186/s40064-016-1920-3 |
Ejemplares similares
-
Weight Loss Reversed Obesity-Induced HGF/c-Met Pathway and Basal-Like Breast Cancer Progression
por: Sundaram, Sneha, et al.
Publicado: (2014) -
Obesity-Mediated Regulation of HGF/c-Met Is Associated with Reduced Basal-Like Breast Cancer Latency in Parous Mice
por: Sundaram, Sneha, et al.
Publicado: (2014) -
Higher cMET dependence of sacral compared to clival chordoma cells: contributing to a better understanding of cMET in chordoma
por: Lohberger, Birgit, et al.
Publicado: (2021) -
Targeting the HGF-cMET Axis in Hepatocellular Carcinoma
por: Venepalli, Neeta K., et al.
Publicado: (2013) -
Role of cMET in the Development and Progression of Colorectal Cancer
por: Pérez-Vargas, Juan Carlos Samamé, et al.
Publicado: (2013)